Novanta Inc, together with its subsidiaries, designs, manufactures, markets, and sells photonics, vision, and precision motion components and sub-systems to original equipment manufacturers in the medical and industrial markets worldwide. The company's Photonics segment offers photonics-based solutions, including laser scanning and laser beam delivery, CO2 laser, continuous wave and ultrafast laser, and optical light engine products for photonics-based applications, such as industrial material processing, metrology, medical and life science imaging, DNA sequencing, and medical laser procedures.
Read More…
Industry, Sector and Symbol
Industry Miscellaneous electrical machinery, equipment, & supplies
Sub-IndustryN/A
SectorComputer and Technology
Phone781-266-5700
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$614.34 million
Profitability
Miscellaneous
Employees2,133
Next Earnings DateN/A
OptionableOptionable
Novanta (NASDAQ:NOVT) Frequently Asked Questions
What is Novanta's stock symbol?
Novanta trades on the NASDAQ under the ticker symbol "NOVT."
How were Novanta's earnings last quarter?
Novanta Inc (NASDAQ:NOVT) posted its quarterly earnings results on Wednesday, February, 26th. The technology company reported $0.55 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of $0.54 by $0.01. The technology company had revenue of $159.70 million for the quarter, compared to the consensus estimate of $157.08 million. Novanta had a return on equity of 20.01% and a net margin of 6.94%. The company's quarterly revenue was up 2.2% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.55 EPS. View Novanta's Earnings History.
What guidance has Novanta issued on next quarter's earnings?
Novanta updated its first quarter earnings guidance on Wednesday, February, 26th. The company provided earnings per share (EPS) guidance of $0.34-0.42 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.52. The company issued revenue guidance of ~$144-154 million, compared to the consensus revenue estimate of $152.95 million.
What price target have analysts set for NOVT?
1 brokerages have issued 12-month price targets for Novanta's stock. Their forecasts range from $81.00 to $81.00. On average, they anticipate Novanta's share price to reach $81.00 in the next twelve months. This suggests that the stock has a possible downside of 12.0%. View Analyst Price Targets for Novanta.
What is the consensus analysts' recommendation for Novanta?
1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Novanta in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Novanta.
Has Novanta been receiving favorable news coverage?
Media coverage about NOVT stock has trended somewhat negative on Thursday, InfoTrie reports. InfoTrie scores the sentiment of news coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Novanta earned a news impact score of -1.0 on InfoTrie's scale. They also gave press coverage about the technology company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the company's share price in the near term. View News Stories for Novanta.
Are investors shorting Novanta?
Novanta saw a drop in short interest in the month of January. As of January 31st, there was short interest totalling 704,800 shares, a drop of 6.0% from the January 15th total of 749,800 shares. Based on an average daily volume of 139,700 shares, the days-to-cover ratio is currently 5.0 days. Approximately 2.1% of the shares of the company are short sold. View Novanta's Current Options Chain.
Who are some of Novanta's key competitors?
Some companies that are related to Novanta include CAE (CAE), Energizer (ENR), Integer (ITGR), Spectrum Brands (SPB), Atkore International Group (ATKR), FuelCell Energy (FCEL), Ultralife (ULBI), Arotech (ARTX), Flux Power (FLUX), Sono-Tek (SOTK), Polar Power (POLA), CBAK Energy Technology (CBAT), Security Devices International (SDEV), Evans & Sutherland Computer (ESCC) and mPhase Technologies (XDSL).
What other stocks do shareholders of Novanta own?
Who are Novanta's key executives?
Novanta's management team includes the folowing people:
- Mr. Matthijs Glastra, CEO & Director (Age 50)
- Mr. Robert J. Buckley, Chief Financial Officer (Age 45)
- Mr. Brian S. Young, Chief HR Officer (Age 50)
- Mr. Peter L. Chang, VP, Corp. Controller & Chief Accounting Officer (Age 54)
- Mr. Heinrich Dreyer, Group Pres of Minimally Invasive Surgery
Who are Novanta's major shareholders?
Novanta's stock is owned by a number of of institutional and retail investors. Top institutional investors include Alliancebernstein L.P. (5.30%), William Blair Investment Management LLC (2.90%), Artisan Partners Limited Partnership (2.83%), Conestoga Capital Advisors LLC (2.73%), Janus Henderson Group PLC (2.06%) and Paradice Investment Management LLC (2.00%). Company insiders that own Novanta stock include Matthijs Glastra, Peter L Chang, Robert Buckley and Stephen W Bershad. View Institutional Ownership Trends for Novanta.
Which major investors are selling Novanta stock?
NOVT stock was sold by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC, Goldman Sachs Group Inc., Fred Alger Management LLC, AXA, Westwood Holdings Group Inc., Alliancebernstein L.P., PNC Financial Services Group Inc. and Stifel Financial Corp. Company insiders that have sold Novanta company stock in the last year include Matthijs Glastra, Peter L Chang, Robert Buckley and Stephen W Bershad. View Insider Buying and Selling for Novanta.
Which major investors are buying Novanta stock?
NOVT stock was purchased by a variety of institutional investors in the last quarter, including Eventide Asset Management LLC, Conestoga Capital Advisors LLC, William Blair Investment Management LLC, Artisan Partners Limited Partnership, GW&K Investment Management LLC, Sei Investments Co., Geode Capital Management LLC and Janus Henderson Group PLC. View Insider Buying and Selling for Novanta.
How do I buy shares of Novanta?
Shares of NOVT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Novanta's stock price today?
One share of NOVT stock can currently be purchased for approximately $92.04.
How big of a company is Novanta?
Novanta has a market capitalization of $3.23 billion and generates $614.34 million in revenue each year. The technology company earns $49.11 million in net income (profit) each year or $2.16 on an earnings per share basis. Novanta employs 2,133 workers across the globe.View Additional Information About Novanta.
What is Novanta's official website?
How can I contact Novanta?
Novanta's mailing address is 125 Middlesex Turnpike, Bedford MA, 01730. The technology company can be reached via phone at 781-266-5700 or via email at [email protected]
MarketBeat Community Rating for Novanta (NASDAQ NOVT)
MarketBeat's community ratings are surveys of what our community members think about Novanta and other stocks. Vote "Outperform" if you believe NOVT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NOVT will underperform the S&P 500 over the long term. You may vote once every thirty days.
